Small molecules targeting p53 to improve antitumor therapy

被引：12

作者：

Beretta, G. L. ^{[1
]}

Gatti, L. ^{[1
]}

Benedetti, V. ^{[1
]}

Perego, P. ^{[1
]}

Zunino, F. ^{[1
]}

机构：

[1] Ist Nazl Tumori, Fdn IRCCS, Dept Expt Oncol & Labs, I-20133 Milan, Italy

来源：

MINI-REVIEWS IN MEDICINAL CHEMISTRY | 2008年 / 8卷 / 09期

关键词：

p53; nutlins; pifithrins; histone deacetylase inhibitors; ubiquitin ligase inhibitors; apoptosis; cancer cells; drug combination;

D O I：

10.2174/138955708785132774

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Small molecules targeting p53 represent an emerging group of potentially useful agents for the improvement of antitumor therapy. These modulators include agents that activate wild-type p53 or reactivate mutant p53 and inhibitors of p53 functions. Preclinical evidences support the interest of combination strategies with conventional antitumor agents.

引用

页码：856 / 868

页数：13

共 100 条

[91] Pifithrin-α enhances chemosensitivity by a p38 mitogen-activated protein kinase-dependent modulation of the eukaryotic initiation factor 4E in malignant cholangiocytes [J].

Wehbe, Hania ;

Henson, Roger ;

Lang, Molly ;

Meng, Fanyin ;

Patel, Tushar .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 319 (03) :1153-1161

[92]

Willis A. C., 2002, Current Molecular Medicine (Hilversum), V2, P329, DOI 10.2174/1566524023362474

[93] Pharmaceutical-mediated inactivation of p53 sensitizes U87MG glioma cells to BCNU and temozolomide [J].

Xu, GW ;

Mymryk, JS ;

Cairncross, JG .

INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (02) :187-192

[94] Histone deacetylase inhibitors: molecular mechanisms of action [J].

Xu, W. S. ;

Parmigiani, R. B. ;

Marks, P. A. .

ONCOGENE, 2007, 26 (37) :5541-5552

[95] Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells [J].

Yang, YL ;

Ludwig, RL ;

Jensen, JP ;

Pierre, SA ;

Medaglia, MV ;

Davydov, IV ;

Safiran, YJ ;

Oberoi, P ;

Kenten, JH ;

Phillips, AC ;

Weissman, AM ;

Vousden, KH .

CANCER CELL, 2005, 7 (06) :547-559

[96] Trp53 loss during in vitro selection contributes to acquired Ara-C resistance in acute myeloid leukemia [J].

Yin, Bin ;

Kogan, Scott C. ;

Dickins, Ross A. ;

Lowe, Scott W. ;

Largaespada, David A. .

EXPERIMENTAL HEMATOLOGY, 2006, 34 (05) :631-641

[97] Pifithrin-α supresses p53 and protects cochlear and vestibular hair cells from cisplatin-induced apoptosis [J].

Zhang, M ;

Liu, W ;

Ding, D ;

Salvi, R .

NEUROSCIENCE, 2003, 120 (01) :191-205

[98]

Zhang XT, 2006, ONCOL REP, V16, P563

[99] The initial evaluation of non-peptidic small-molecule HDM2 inhibitors based on p53-HDM2 complex structure [J].

Zhao, JH ;

Wang, MJ ;

Chen, J ;

Luo, AP ;

Wang, XQ ;

Wu, M ;

Yin, DL ;

Liu, ZH .

CANCER LETTERS, 2002, 183 (01) :69-77

[100] Novel p53 inactivators with neuroprotective action: Syntheses and pharmacological evaluation of 2-imino-2,3,4,5,6,7-hexahydrobenzothiazole and 2-imino-2,3,4,5,6,7-hexahydrobenzoxazole derivatives [J].

Zhu, XX ;

Yu, QS ;

Cutler, RG ;

Culmsee, CW ;

Holloway, HW ;

Lahiri, DK ;

Mattson, MP ;

Greig, NH .

JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (23) :5090-5097

← 1 2 3 4 5 6 7 8 9 10 →